Assessing Ovarian Function During Prolonged Implant Use

CompletedOBSERVATIONAL
Enrollment

117

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

December 30, 2021

Study Completion Date

December 30, 2021

Conditions
Contraception
Interventions
DEVICE

Etonogestrel Implant

Ovarian function will be assessed with weekly serum progesterone levels. Participants will undergo weekly venipuncture for a total of four draws over a 30 day period. Participants will also complete a bleeding diary to assess daily bleeding patterns for the 30 day study period.

Trial Locations (2)

63108

Planned Parenthood of the St. Louis Region and Southwest Missouri, St Louis

63110

Washington University in St Louis, St Louis

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Planned Parenthood of the St. Louis Region and Southwest Missouri

OTHER

NCT03058978 - Assessing Ovarian Function During Prolonged Implant Use | Biotech Hunter | Biotech Hunter